Ajax Health

Managing Partner at Ajax and CFO of Ajax companies Cordis-X and Maverix Medical, with over 25 years of experience. Previously CFO of EPIX Therapeutics, Spirox, and CV Ingenuity; holds an MBA from Stanford.

CEO and Managing Partner at Ajax, holding leadership roles across Ajax companies. Serial medtech entrepreneur who co-founded and led EPIX Therapeutics, Spirox, and CV Ingenuity; holds an MBA from Harvard and a BA from Stanford.

Partner and SVP Operations at Ajax and COO at Cordis-X. Previously COO/EVP at Kedalion Therapeutics and an Associate Partner at McKinsey; holds a BA from Brown and an MBA from Wharton.

Partner and SVP Medical at Ajax and a practicing interventional radiologist. Former Vice-Chair of Radiology at Memorial Sloan Kettering; holds a BS from Duke and an MD from Stanford.

Partner and SVP Finance at Ajax, VP of Finance at Maverix Medical and CFO of Protaryx Medical. Previously CFO of Symic Bio and controller at CV Ingenuity; holds a BA from the University of San Diego.

Operating Partner at Ajax with over 30 years of medical device R&D experience. Former Chief Strategy Officer of Ajax company Cortex and SVP of R&D at EPIX Therapeutics; credited with 90 US patents.

Partner at Ajax and former COO of Ajax company Cortex. Holds a JD from Harvard Law School and a BA from Stanford; previously an account manager at Oracle.

Partner at Ajax and COO of Ajax company Maverix Medical. Previously an associate at Latham & Watkins and a judicial law clerk to Chief Justice John Roberts; holds a JD from Harvard Law School and a BS from USC.

Partner and SVP Legal at Ajax and CFO of Ajax company XII Medical. Previously an associate at Cooley focused on life sciences financings; holds a JD from Harvard Law and a BS in economics from Duke.

Vice President at Ajax and Director of Business Development at Maverix Medical, having contributed to multiple Ajax platforms. Holds BA and BE degrees in biomedical engineering from Dartmouth.

Vice President at Ajax and board observer at XII Medical, with prior roles at Ajax companies Cortex and Cordis. Previously an investment banking analyst at DBO Partners; holds a BA from Dartmouth.

Chief Compliance Officer at Ajax Health Management Company. Previously spent nearly a decade at ICONIQ Capital as Senior Counsel; holds a JD from Golden Gate University.

Controller at Ajax, previously a Senior Finance Manager at Venrock. Holds an MS in accounting from San Jose State University.

Entrepreneur in Residence at Ajax and CCO of Ajax company Maverix Medical, with 24 years of medtech commercial experience including 13 years at Medtronic and 11 at Boston Scientific. Holds an MBA from Columbia and a BA from Villanova.

Executive Assistant at Ajax with a background in arts administration and support roles at Etsy, Blue Apron, and Founders Pledge. Holds a BS in music education.

Head of Human Resources at Ajax and at Ajax company XII Medical, with over 13 years of HR leadership in life sciences and enterprise software. Previously led People & Talent at Orca Bio; holds a BA from UC Berkeley.

Executive Assistant at Ajax, previously Marketing Director at Silver Linings Technology and an EA at Aisling Capital. Holds an MFA in directing.

VP of Engineering at Ajax and VP of R&D at Maverix Medical, with 15 years of medtech R&D experience. Previously VP of R&D at Half Moon Medical and a principal engineer at Twelve; holds an MS from Stanford and a BS from MIT.

HR Manager at Ajax with over 15 years in the startup medical device industry. Previously HR Manager at EPIX Therapeutics and in HR roles at Spirox; holds a BS in marketing from the University of Phoenix.

Associate at Ajax, previously a Senior Analyst at ClearView Healthcare Partners. Holds a BA in neuroscience from Harvard College.

Named among the top healthcare investors of 2025 by GrowthCap.

Johnny Hooper is an Associate at March Capital supporting the investment team with diligence, deal execution, and operational work. A UC Berkeley graduate and two-time Olympic water polo player (Tokyo and Paris, where he won bronze), he previously worked in Goldman Sachs' TMT group on M&A, IPOs, and financings.